Experimental drug could help some with hepatitis B
WASHINGTON — A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers recently reported. In two international studies, about 1 in 5 patients given the ...